Abstract
Clinical manifestations of coronavirus disease 2019 (COVID-19) range from mild self-limiting illness to multi-organ dysfunction and acute respiratory distress syndrome (ARDS). Also, leptospirosis manifests as mild or asymptomatic infection, and only a small number of patients progress to ARDS and develop systemic manifestation. COVID-19 and leptospira co-infection can have fatal outcomes because of augmented pathophysiological manifestations of both the disease.
Original language | English (US) |
---|---|
Pages (from-to) | 131-134 |
Number of pages | 4 |
Journal | Journal of Cellular and Molecular Anesthesia |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - Apr 1 2022 |
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine
- Pharmacology (medical)